In vitro assessments of antimicrobial activity - task area c
Ended Awarded Last action
- Contract number
- 75N93019D00013
- Awardee
-
New York University UEI M5SZJ6VHUHN8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- RFPNIAIDDMIDNIHAI2017091 Solicitation number
- In Vitro Assessments of Antimicrobial Activity Award Notice · Posted Nov 14, 2017
- Last date to order 100% complete
- IDV ceiling
- $30,000,000.00
- Maximum order
- $30,000,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 27 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
Award details come from SAM.gov/FPDS.
About this IDV
New York University School of Medicine was awarded a multiple award indefinite delivery contract by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases. With a potential value of $30 million, the contract supports Task Area C of the In Vitro Assessments of Antimicrobial Activity master IDIQ. No set-aside was used for the award.
Under the contract, NYU School of Medicine will provide a range of epidemiology and infection prevention research and services. This includes healthcare-associated infection surveillance, reporting, prevention research, and scientific services to support the Safe Healthcare Epidemiology, Prevention, and Research Development Program at the Centers for Disease Control and Prevention. As a prime contractor on the multiple award IDV, NYU School of Medicine is eligible to receive task orders through January 2026 to conduct these services.
The award aims to advance the CDC's mission of protecting public health and safety through leadership and excellence in health promotion, disease prevention, and preparedness. NYU School of Medicine's research and services will inform efforts to reduce and prevent facility-associated infections, a significant patient safety issue. Performance will take place both on-site and off-site at NYU School of Medicine and other locations as required.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N93019D00013?
75N93019D00013 was awarded to New York University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on January 11, 2019.
How much is contract 75N93019D00013 worth?
75N93019D00013's own ceiling is $30,000,000. A single order can be worth up to $30,000,000.
Who can order from contract 75N93019D00013?
75N93019D00013 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N93019D00013 part of a contract vehicle?
Yes. 75N93019D00013 is part of In Vitro Assessments of Antimicrobial Activity (IVAAA).
Was contract 75N93019D00013 competed?
The extent of competition for 75N93019D00013 was full and open competition. The government received 27 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV